×
Surmodics Operating Expenses 2010-2024 | SRDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Surmodics operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
Surmodics Operating Expenses 2010-2024 | SRDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Surmodics operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$231B
Boston Scientific (BSX)
$155.5B
Stryker (SYK)
$147.4B
EssilorLuxottica (ESLOY)
$140.8B
Medtronic (MDT)
$112.8B
Lonza Group Ag (LZAGY)
$47.1B
Haleon (HLN)
$44.8B
GE HealthCare Technologies (GEHC)
$42.1B
Agilent Technologies (A)
$39B
ResMed (RMD)
$34.2B
Terumo (TRUMY)
$26.3B
Koninklijke Philips (PHG)
$23.5B
Zimmer Biomet Holdings (ZBH)
$20.6B
Insulet (PODD)
$20.2B
Baxter (BAX)
$17.1B
Sunny Optical Technology (SNPTF)
$11.3B
Smith & Nephew SNATS (SNN)
$11.2B
BellRing Brands (BRBR)
$9.5B
Bio-Rad Laboratories (BIO)
$8B
Demant (WILYY)
$7.9B
Lantheus Holdings (LNTH)
$5.6B
Prestige Consumer Healthcare (PBH)
$4.2B
ICU Medical (ICUI)
$4B
Envista Holdings (NVST)
$3.7B
Perrigo (PRGO)
$3.4B
Haemonetics (HAE)
$3.2B
Shandong Weigao Medical Polymer (SHWGF)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.8B
LeMaitre Vascular (LMAT)
$2.3B